What to expect from immunotherapy for lung cancer

Immunotherapy helps immune cells identify and attack cancer cells. It may be offered alone or alongside other cancer treatments, depending on the type and stage of lung cancer, test results, and your general health. Treatment is commonly delivered through an intravenous infusion at a clinic. Your team will explain the medicine, schedule, observation period, and scan plan. A response may take time to assess, so symptoms alone do not show whether treatment is working.

Tell the oncology team about medicines, supplements, allergies, autoimmune conditions, previous transplants, and any changes in breathing or energy. Keep a simple record of fever, cough, rash, diarrhoea, pain, appetite, and fatigue. Do not start a new medicine without checking first. Attend blood tests and scans as arranged; these help the team decide whether to continue, pause, or adjust treatment. Ask who to contact outside clinic hours.

Contact your cancer team promptly for worsening breathlessness, chest pain, a new or persistent cough, fever, severe diarrhoea, marked weakness, confusion, yellowing of the skin, or a spreading rash. Seek emergency help for severe difficulty breathing, fainting, sudden confusion, or chest pain that does not settle. Immune-related inflammation can affect the lungs and other organs, and early assessment can guide treatment.

Ask which immunotherapy medicine is planned, why it suits your cancer, how infusion visits will run, which tests are needed, and which symptoms require a same-day call. Ask how other medicines or health conditions may affect treatment and what happens if a dose is delayed.